MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations
Strong demand predicted across all life science markets
Dutch biotechnology company Molecular Biology Systems(MBS) today announced will launch its revolutionary NEXTGENPCR thermal cycler through CAMLAB, the UK’s leading independent scientific instrumentation distributor. First showing will be at the upcoming Lab Innovations at Birmingham NEC, Nov 1-2. The UK remains a key market for the life sciences, with continuing public and private infrastructure investment – including the recently announced £146 million from the Industrial Strategy Challenge Fund.
Read the whole article: MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations
